Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 4Breast Neoplasms 3Stomach Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Tongue Squamous Cell Carcinoma 1Squamous Non-Small Cell Lung Cancer SqNSCLC 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Resectable Esophageal Squamous Cell Carcinoma 1Rare Tumour 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Hypoxia 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Biliary Tract Neoplasms 1Advanced Non-squamous Non-small-cell Lung Cancer 1

Interventions

fludarabine 1Temozolomide 1Radiotherapy 1Injections 1Cyclophosphamide 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hypoxia × Albumin-Bound Paclitaxel × Clear all
NCT06939270 2025-04-22

CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors

Chinese PLA General Hospital

Phase 1/2 Not yet recruiting
30 enrolled

Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡